Visual Retinocortical Function in Dementia of the Alzheimer Type

Background: Some histological investigations have reported anomalies in the primary visual pathways of individuals with dementia of the Alzheimer type (DAT), while others have suggested that these visual structures are spared by the disease process. Objectives: This study was conducted to address this issue of substantial controversy. We determined in vivo whether DAT alters the functioning of the primary visual pathways by evaluating pattern-reversal electroretinograms (ERGs) and cortical visual evoked potentials (VEPs). Methods: Twenty-seven individuals with mild to moderate DAT and 27 age- and sex-matched control subjects were included in the investigation. ERG and VEP recordings were obtained from all participants with the use of a clinical electrodiagnostic system. Stimulus conditions were biased towards a preferential response from the magnocellular and parvocellular subdivisions of the visual system. Results: Amplitude and latency of the ERG were not affected by DAT. The VEP amplitude was not attenuated in DAT individuals, but there was a delay in the latency of the VEPs arising from both magnocellular and parvocellular streams of visual processing. Conclusion: Our results indicate that while the inner retina appears to be spared by the disease process, the visual function is altered upstream in the retinocortical visual pathways of individuals with DAT.

[1]  E Peli,et al.  Retinal nerve fiber layer abnormalities in Alzheimer's disease. , 2009, Acta ophthalmologica Scandinavica.

[2]  H. Chertkow,et al.  Neuroretinal function is normal in early dementia of the Alzheimer type , 2001, Neurobiology of Aging.

[3]  H Kergoat,et al.  An evaluation of the retinal nerve fiber layer thickness by scanning laser polarimetry in individuals with dementia of the Alzheimer type. , 2001, Acta ophthalmologica Scandinavica.

[4]  S. Bhattacharya,et al.  Electrophysiological findings in Dominant Optic Atrophy (DOA) linking to the OPA1 locus on chromosome 3q 28-qter , 1998, Documenta Ophthalmologica.

[5]  Walter G. Sannita,et al.  Cholinergic modulation, visual function and Alzheimer's dementia , 1997, Vision Research.

[6]  Piero Antuono,et al.  Cytochrome oxidase in Alzheimer's disease: Biochemical, histochemical, and immunohistochemical analyses of the visual and other systems , 1997, Vision Research.

[7]  P Pietrini,et al.  Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications. , 1996, The American journal of psychiatry.

[8]  K. Jobst,et al.  Myelinated axon number in the optic nerve is unaffected by Alzheimer's disease. , 1995, The British journal of ophthalmology.

[9]  S. Corkin,et al.  Visual dysfunction predicts cognitive deficits in Alzheimer's disease. , 1995, Optometry and vision science : official publication of the American Academy of Optometry.

[10]  C. Curcio,et al.  Retinal ganglion cells in Alzheimer's disease and aging , 1993, Annals of neurology.

[11]  E. Brodie,et al.  Flash and Pattern Reversal Visual Evoked Responses in Normal and Demented Elderly , 1992, Cortex.

[12]  R. Hichwa,et al.  In vivo Muscarinic Cholingeric Receptor Imaging in Human Brain with [11C]Scopolamine and Positron Emission Tomography , 1992 .

[13]  JH Maunsell,et al.  Does primate motion perception depend on the magnocellular pathway? , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[14]  A M Murro,et al.  Effects of scopolamine on visual evoked potentials in aging and dementia. , 1991, Electroencephalography and clinical neurophysiology.

[15]  W. J. Jackson,et al.  Lesions of nucleus basalis alter ChAT activity and EEG in rat frontal neocortex. , 1991, Electroencephalography and clinical neurophysiology.

[16]  J. Maunsell,et al.  The effects of parvocellular lateral geniculate lesions on the acuity and contrast sensitivity of macaque monkeys , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[17]  R. Ritch,et al.  Optic nerve head and nerve fiber layer in Alzheimer's disease. , 1991, Archives of ophthalmology.

[18]  J. Morrison,et al.  Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex , 1990, The Journal of comparative neurology.

[19]  R. Lévy,et al.  Visual evoked potentials in Alzheimer's disease: correlations with age and severity. , 1990, Electroencephalography and clinical neurophysiology.

[20]  R. Robertson,et al.  Relationships between patterns of acetylcholinesterase activity and geniculocortical terminal fields in developing and mature rat visual cortex. , 1990, Brain research. Developmental brain research.

[21]  V. Iragui,et al.  Abnormal pattern electroretinogram in Alzheimer's disease: Evidence for retinal ganglion cell degeneration? , 1989, Annals of neurology.

[22]  M. Barris,et al.  Abnormal pattern electroretinograms in patients with senile dementia of the alzheimer type , 1989, Annals of neurology.

[23]  L. Schneider,et al.  Visual evoked potentials in dementia: A meta-analysis and empirical study of Alzheimer's disease patients , 1989, Biological Psychiatry.

[24]  R. Hansen,et al.  Scotopic stimulus/response relations of the B-wave of the electroretinogram , 1988, Documenta Ophthalmologica.

[25]  N. Chu,et al.  Pattern-reversal visual evoked potentials: latency changes with gender and age. , 1987, Clinical EEG.

[26]  M J Campbell,et al.  Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[27]  D. Kaufman,et al.  Effects of age and sex on pattern electroretinograms and visual evoked potentials. , 1987, Electroencephalography and clinical neurophysiology.

[28]  P. O'Connor,et al.  The pattern ERG in man following surgical resection of the optic nerve. , 1987, Investigative ophthalmology & visual science.

[29]  C. E. Wright,et al.  Pathology of the optic nerve and visual association areas. Information given by the flash and pattern visual evoked potential, and the temporal and spatial contrast sensitivity function. , 1987, Brain : a journal of neurology.

[30]  William H. Merigan,et al.  Spatio-temporal vision of macaques with severe loss of Pβ retinal ganglion cells , 1986, Vision Research.

[31]  C. Miller,et al.  Optic-nerve degeneration in Alzheimer's disease. , 1986, The New England journal of medicine.

[32]  L. Maffei,et al.  Pattern ERG in the monkey after section of the optic nerve , 1986, Behavioural Brain Research.

[33]  C. E. Wright,et al.  The flash and pattern VEP as a diagnostic indicator of dementia , 1986, Documenta Ophthalmologica.

[34]  C. E. Wright,et al.  Primary Presenile Dementia: The Use of the Visual Evoked Potential as a Diagnostic Indicator , 1985, British Journal of Psychiatry.

[35]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[36]  Marshal F. Folstein,et al.  Aging of the Brain and Dementia , 1983 .

[37]  C. P. Hughes,et al.  Visual evoked potentials in mild senile dementia of Alzheimer type. , 1983, Electroencephalography and clinical neurophysiology.

[38]  Larry L. Butcher,et al.  Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices: A combined fluorescent tracer and acetylcholinesterase analysis , 1982, Brain Research Bulletin.

[39]  A. Fiorentini,et al.  Electroretinographic responses to alternating gratings before and after section of the optic nerve. , 1981, Science.

[40]  Kazuo Kawasaki,et al.  New approaches to ophthalmic electrodiagnosis by retinal oscillatory potential, drug-induced responses from retinal pigment epithelium and cone potential , 1979, Documenta Ophthalmologica.

[41]  P. Davies,et al.  SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.

[42]  R. Katzman.,et al.  Editorial: The prevalence and malignancy of Alzheimer disease. A major killer. , 1976, Archives of neurology.

[43]  R. Hu Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) , 2003 .

[44]  Canadian study of health and aging: study methods and prevalence of dementia. , 1994, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[45]  R. Hichwa,et al.  In vivo muscarinic cholinergic receptor imaging in human brain with [11C]scopolamine and positron emission tomography. , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[46]  I. Gottlob,et al.  Pattern electroretinogram and luminance electroretinogram in Alzheimer's disease. , 1991, Journal of neural transmission. Supplementum.

[47]  William H. Merigan,et al.  P and M Pathway Specialization in the Macaque , 1991 .

[48]  A. Sadun,et al.  Optic nerve damage in Alzheimer's disease. , 1990, Ophthalmology.

[49]  L. Berg,et al.  Mild senile dementia of the Alzheimer's type: diagnostic criteria and natural history. , 1988, The Mount Sinai journal of medicine, New York.

[50]  B. Reisberg Functional assessment staging (FAST). , 1988, Psychopharmacology bulletin.

[51]  L. Amaducci,et al.  Aging of the brain and dementia , 1980 .